Autosomal Dominant Polycystic Kidney Disease
📧 Sign up to get email alerts when something new happens for Autosomal Dominant Polycystic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-25Clinical Trial Update: Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal Insufficiency [Phase 2, Phase 3]
A Phase 2/3 study evaluating sirolimus in autosomal dominant polycystic kidney disease with severe renal insufficiency has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-11-21Clinical Trial Update: Octreotide in Severe Polycystic Liver Disease [Phase 2, Phase 3]
This clinical trial update reports completion and posted results for phase 2/3 studies of octreotide in severe polycystic liver disease, spo…
-
CLINICAL_TRIALS trial_result · 2012-07-31Clinical Trial Update: The Relation Between Uric Acid Level and Endothelial Dysfunction in Patients With Polycystic Kidney Disease
The document reports on a study exploring the relationship between uric acid levels and endothelial dysfunction in patients with autosomal d…
-
CLINICAL_TRIALS trial_result · 2012-07-03Clinical Trial Update: The Vienna RAP Pilot Study [NA]
The Vienna RAP Pilot Study for autosomal dominant polycystic kidney disease has completed according to the trial record.
-
CLINICAL_TRIALS trial_result · 2012-02-27Clinical Trial Update: Water as Therapy in Autosomal Dominant Polycystic Kidney Disease (ADPKD) [NA]
A completed clinical trial from the University of Kansas explored the use of water therapy as a treatment approach for Autosomal Dominant Po…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-02-19Clinical Trial Update: Adrenal Functions in Autosomal Dominant Polycystic Kidney Disease [NA]
A clinical trial evaluating adrenal function in autosomal dominant polycystic kidney disease has completed; sponsor is Istanbul University.
-
CLINICAL_TRIALS trial_result · 2009-02-17Clinical Trial Update: Lanreotide as Treatment of Polycystic Livers [Phase 2, Phase 3]
Phase 2/3 clinical trial of lanreotide for polycystic liver disease has completed, indicating ongoing evaluation for this indication.
-
CLINICAL_TRIALS trial_result · 2006-06-27Clinical Trial Update: Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis [Phase 1]
Phase 1 trial assessing the effects of systemic nitric oxide inhibition on renal hemodynamics in people with autosomal dominant polycystic k…